Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Interventions

Dexamethasone 51 Aprepitant 39 Palonosetron 37 Ondansetron 31 Granisetron 22 Calcium Dobesilate 14 fosaprepitant 13 Olanzapine 13 Therapeutics 8 dexamethasone acetate 7 ramosetron 6 netupitant, palosentron drug combination 6 casopitant 6 Tropisetron 6 Cyclophosphamide 6 dexamethasone 21-phosphate 5 Radiotherapy 5 Metoclopramide 5 Doxorubicin 5 netupitant 4 dolasetron 4 Surveys and Questionnaires 4 Dronabinol 4 Acupressure 4 Yoga 3 Vincristine 3 Tablets 3 Psychiatric Rehabilitation 3 Prochlorperazine 3 Lorazepam 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × NDC80 protein, human × Clear all

NCT01366599 2017-05-24

CV Events in Emetogenic Chemotherapy

GlaxoSmithKline

12,058 enrolled

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡